Skip to content

Perspectives and Management of Atypical Asthma

Perspectives and Management of Atypical Asthma in Chinese Specialists and Primary Care Practitioners -- A Nationwide Questionnaire Survey.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04932551
Enrollment
5000
Registered
2021-06-21
Start date
2021-01-15
Completion date
2021-12-30
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

To evaluate the awareness/knowledge, clinical practice of atypical asthma among respiratory specialists and primary care practitioners (PCPs) in China.A total of 1166 respiratory specialists and 799 PCPs participated in the questionnaire survey via WeChat. The questionnaire included six major items, divided into physician demographic characteristics, awareness, diagnosis, medication prescription, assessment/education, and proposal.

Interventions

OTHERQuestionnaire

physicians will participate in the questionnaire via WeChat. The questionnaire included six main items: physician demographic characteristics, awareness, diagnosis, medical prescription, assessment/education, and proposal.

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Grade Hospital Respiratory Doctor,Pediatrician,And doctors in primary hospitals

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Complete the questionnaire30 minutesThe questionnaire included six main items: physician demographic characteristics, awareness, diagnosis, medical prescription, assessment/education, and proposal.

Countries

China

Contacts

Primary ContactHuaqiong Huang
huanghuaqiong163@163.com15005818703

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026